Browsing by Subject "radiation oncology"

Now showing 1 - 5 of 5
  • Thumbnail Image
    Item
    Analysis of Virtual Versus In-Person Prospective Peer Review Workflow in a Multisite Academic Radiation Oncology Department
    (Elsevier, 2021-11) McClelland, Shearwood III; Amy Achiko, Flora; Bartlett, Gregory K.; Watson, Gordon A.; Holmes, Jordan A.; Rhome, Ryan M.; DesRosiers, Colleen M.; Hutchins, Karen M.; Shiue, Kevin; Agrawal, Namita; Radiation Oncology, School of Medicine
    Purpose In radiation oncology, peer review is a process where subjective treatment planning decisions are assessed by those independent of the prescribing physician. Before March 2020, all peer review sessions occurred in person; however due to the COVID-19 pandemic, the peer-review workflow was transitioned from in-person to virtual. We sought to assess any differences between virtual versus in-person prospective peer review. Methods and Materials Patients scheduled to receive nonemergent nonprocedural radiation therapy (RT) were presented daily at prospective peer-review before the start of RT administration. Planning software was used, with critical evaluation of several variables including treatment intent, contour definition, treatment target coverage, and risk to critical structures. A deviation was defined as any suggested plan revision. Results In the study, 274 treatment plans evaluated in-person in 2017 to 2018 were compared with 195 plans evaluated virtually in 2021. There were significant differences in palliative intent (36% vs 22%; P = .002), but not in total time between simulation and the start of treatment (9.2 vs 10.0 days; P = .10). Overall deviations (8.0% in-person vs 2.6% virtual; P = .015) were significantly reduced in virtual peer review. Conclusions Prospective daily peer review of radiation oncology treatment plans can be performed virtually with similar timeliness of patient care compared with in-person peer review. A decrease in deviation rate in the virtual peer review setting will need to be further investigated to determine whether virtual workflow can be considered a standard of care.
  • Thumbnail Image
    Item
    An Intracranial Hemorrhage Wrapped in an Enigma
    (Elsevier, 2019-10) McClelland, Shearwood, III; Saito, Naoyuki G.; Radiation Oncology, School of Medicine
    An 88-year-old man with Alzheimer's dementia who previously received a diagnosis of solitary Fuhrman grade 2 renal cell carcinoma1 managed with active surveillance presented to the emergency department for progressive left-sided headache and difficulty recognizing numbers and letters. He and his family denied history of trauma, fall, or anticoagulant use. This occurred 1 week after presenting to the same emergency department with a headache and being discharged home after negative head computed tomography, 2 months after spontaneous subarachnoid hemorrhage involving the right central sulcus, and 11 months after transient ischemic attack symptoms with negative workup.
  • Thumbnail Image
    Item
    Responses to the 2017 ‘1 Million Gray Question’: ASTRO membership’s opinions on the most important research question facing radiation oncology
    (Elsevier, 2018-10) Dominello, Michael M.; Keen, Judith C.; Beck, Tyler F.; Bayouth, John; Knisely, Jonathan; Carlson, David J.; Mendonca, Marc S.; Mian, Omar; Brock, Kristy K.; Anscher, Mitchell; Hugo, Geoffrey; Moros, Eduardo G.; Singh, Anurag K.; Yu, James B.; Radiation Oncology, School of Medicine
    At the American Society for Radiation Oncology's (ASTRO's) 2017 annual meeting in San Diego, CA, attendees were asked, “What is the most important research question that needs to be answered in the next 3 to 5 years?” This request was meant to start a dialogue, promote thoughtful discussion within our professional community, and help inform topics for ASTRO workshops and focus meetings. Nearly 100 people responded while in attendance at the meeting, with questions that ranged from “How can we remove barriers so low- and middle-income countries can have radiation oncology facilities?” to “What is the exact role of radiation in stage IV disease in combination with immunotherapy or targeted agents to combat resistance development?” to “How can personalized care be better integrated into the oncology and radiation oncology clinical space?”
  • Thumbnail Image
    Item
    Responses to the 2018 and 2019 “One Big Discovery” Question: ASTRO Membership’s Opinions on the Most Important Research Question Facing Radiation Oncology…Where Are We Headed?
    (Elsevier, 2020) Dominello, Michael M.; Sanders, Tim; Anscher, Mitchell; Bayouth, John; Brock, Kristy K.; Carlson, David J.; Hugo, Geoffrey; Joseph, Sabrina; Knisely, Jonathan; Mendonca, Marc S.; Mian, Omar Y.; Moros, Eduardo G.; Singh, Anurag K.; Yu, James B.; Radiation Oncology, School of Medicine
  • Thumbnail Image
    Item
    The surgical nature of radiation oncology should be better reflected in pre-residency training
    (Elsevier, 2019-08-17) McClelland, Shearwood; Brown, Simon A.; Ramirez-Fort, Marigdalia K.; Jaboin, Jerry J.; Zellars, Richard C.; Radiation Oncology, School of Medicine